note
1. The number of unlisted companies is considered to be waived;
2. The national pharmaceutical group zhijun (shenzhen) pharmaceutical co., LTD. Is separately evaluated, and the corresponding sales revenue data is deducted from the consolidated statement of Shanghai modern pharmaceutical co., LTD.
3. Huali medical group co., LTD. Includes the data of subsidiary companies such as jianmin pharmaceutical group co., ltd. and kunming pharmaceutical group co., LTD.
Selection rules
1. The time span of the "top 100 Chinese pharmaceutical industry in 2016" is from January 1, 2016 to December 31, 2016.
2. The selection of statistical indicators is the annual sales income of the pharmaceutical industry (according to Chinese accounting standards).
3. Participate in the selection of objects for registration in China (excluding the subsidiaries of multinational pharmaceutical enterprises in China), and pharmaceutical manufacturing industry as the main business of medicine industrial enterprises, industrial and commercial registration in the enterprise namely, pharmaceutical manufacturing operations in the enterprise in front of the main business scope of the enterprise. If the selection of companies contains pharmaceutical or other non-pharmaceutical components, they will be excluded and then counted.
4. The selection object is calculated by the enterprise group as the statistical unit. In the ranking, the group company or listed company first statistics, if the group company contains the listed company part, the group company first statistics; The scope of the statistics of the group company is the holding company of a wholly owned subsidiary, direct or indirect share of the group company, which is not in the statistical range of the group company.
5. The participants in the selection are not pharmaceutical and veterinary pharmaceutical manufacturers.
6. This ranking results in the selection rules, and the medical economic daily has the right to interpret the list.
